Ardeparin Subcutaneous and Hyaluronidase and rituximab
Determining the interaction of Ardeparin Subcutaneous and Hyaluronidase and rituximab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ardeparin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: Ardeparin (Subcutaneous)
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ardeparin Subcutaneous-Hyaluronidase and trastuzumab
- Ardeparin Subcutaneous-Hyaluronidase injection
- Ardeparin Subcutaneous-Hyaluronidase Injection (Human)
- Ardeparin Subcutaneous-Hyaluronidase Subcutaneous, Injection
- Ardeparin Subcutaneous-Hyate:C
- Ardeparin Subcutaneous-Hybrisil
- Hyaluronidase and rituximab-Aredia
- Hyaluronidase and rituximab-Arestin
- Hyaluronidase and rituximab-Arestin eent
- Hyaluronidase and rituximab-Arestin mucous membrane powder
- Hyaluronidase and rituximab-Arformoterol
- Hyaluronidase and rituximab-Arformoterol inhalation